In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Proteus Biomedical closes $11.6mm Series B round

Executive Summary

Proteus Biomedical (develops devices for congestive heart failure) closed on a two-tranche $11.6mm Series B private placement led by the Carlyle Group, Kaiser Permanente Ventures, and Adams Street Partners. Other new investors Fletcher Spaght Ventures and Asset Management were joined by Proteus incubator Spring Ridge Ventures. The company raised the initial $5.3mm in January.

Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Medical Devices
    • Monitoring Equipment & Devices
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies